Results 1 to 10 of about 453,541 (160)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction

Nature Communications, 2023
The molecular subtypes of adenocarcinoma of the esophagogastric junction (AEG) remain to be identified. Here, the authors perform proteogenomic characterisation of AEG tumours with paired normal adjacent tissues and suggest three proteomic subtypes and ...
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng   +18 more
doaj   +3 more sources

Cervical metastasis of esophagogastric junction cancer

Indian Journal of Pathology and Microbiology, 2012
As cervical metastases in esophagogastric junction cancer are extremely rare, the authors herein report a case. A 63-year-old woman presented with dysphagia since 6 months.
Zhiqiang Cai, Xiaoyan Shu, Junchuan Li, Jiyuan Yang   +3 more
doaj   +2 more sources

Analysis of N6-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction [PDF]

Frontiers in Genetics, 2022
Background: From previous studies, we found that there are more than 100 types of RNA modifications in RNA molecules. m6A methylation is the most common.
Jia-Bin Huang, Bin-Bin Hu, Rong He, Lian He, Chen Zou, Chang-Feng Man, Yu Fan   +6 more
doaj   +3 more sources

Renal cell carcinoma metastasizing to adenocarcinoma of esophagogastric junction: A rare case of tumor-to-tumor metastasis

Indian Journal of Pathology and Microbiology, 2012
The simultaneous occurrence of two primary tumors in one patient is not uncommon, but one tumor metastasizing to another malignancy is a rare phenomenon. Tumor-to-tumor metastasis was first described by Berent in 1902.
Renu Sukumaran, Anitha Mathews, Thara Somanathan, Jayasree Kattoor   +3 more
doaj   +2 more sources

The efficacy of the application of the curative criteria of the 5rd edition Japanese gastric cancer treatment guidelines for early adenocarcinoma of the esophagogastric junction treated by endoscopic submucosal dissection

The Saudi Journal of Gastroenterology, 2021
Background: The curative criteria after endoscopic submucosal dissection for early gastric carcinoma were updated by the Japanese Gastric Cancer Association.
Zhihao Chen, Yong Liu, Lizhou Dou, Yueming Zhang, Shun He, Guiqi Wang   +5 more
doaj   +1 more source

A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report

Surgical Case Reports, 2020
Background Patients with esophagogastric junction cancer are increasing in Western and Eastern countries. Conversely, the clinical significance of surgical resection remains controversial in these patients.
Takako Tanaka, Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Daisuke Matsushita, Keishi Okubo, Takashi Kijima, Yasuto Uchikado, Yoshiaki Kita, Shinichiro Mori, Ken Sasaki, Itaru Omoto, Hiroshi Kurahara, Kosei Maemura, Sumiya Ishigami, Shoji Natsugoe   +15 more
doaj   +1 more source

Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis

BMC Surgery, 2021
Background To analyze whether neoadjuvant chemoradiotherapy (nCRT) could improve the survival for patients with adenocarcinoma of the esophagogastric junction compared with neoadjuvant chemotherapy (nCT).
Jing Li, Qun Zhao, Xueke Ge, Yuzhi Song, Yuan Tian, Shuoshuo Wang, Ming Liu, Xueying Qiao   +7 more
doaj   +1 more source

Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT

BMC Cancer, 2019
Background The prognosis of patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma is still dismal. There are no standard treatment strategies for these patients.
Xiaowen Liu, Jiejie Jin, Hong Cai, Hua Huang, Guangfa Zhao, Ye Zhou, Jianghong Wu, Chunyan Du, Ziwen Long, Yantian Fang, Mingze Ma, Guichao Li, Menglong Zhou, Jiliang Yin, Xiaodong Zhu, Ji zhu, Weiqi Sheng, Dan Huang, Hui Zhu, Zhaozhen Zhang, Qi Lu, Li Xie, Zhen Zhang, Yanong Wang   +23 more
doaj   +1 more source

A unique case of esophageal carcinosarcoma with histopathological diversities

Human Pathology: Case Reports, 2019
We report a 57-year-old Japanese male with esophageal carcinosarcoma with histopathological diversities. The patient complained of dysphagia.
Shohei Matsuo, MD, Yoshiki Nakamura, MD, PhD, Motoki Hiroyoshi, MD, PhD, Ken-ichi Tomiyama, MD, PhD, Terumasa Sashikata, MD, PhD, Nobuyuki Kondo, MD, PhD, Yoshitane Tsukamoto, MD, PhD   +6 more
doaj   +1 more source

Bioinformatic analysis of adenocarcinoma at esophagogastric junction and mutation sites screening of Involucrin gene [PDF]

Jichu yixue yu linchuang, 2022
Objective To detect the gene mutations in patients with Adenocarcinoma at esophagogastric junction(AEG) and to analyze the effect of Involucrin (IVL) mutation on the biological function of tumor cells.
LYU Xue, LI Xue-wei, YANG Ting, ZHENG Jin-xiu, ZHU Zi-he, YANG Tao, XU Jun
doaj   +1 more source